.
MergerLinks Header Logo

Announced

Completed

SoftBank Vision Fund led a $200m Series E funding round in Alto Pharmacy.

Financials

Edit Data
Transaction Value£149m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Venture Capital

Single Bidder

Friendly

Private Equity

Pharmaceuticals

pharmaceutical consulting

drug delivery

United States

Acquisition

Minority

Cross Border

Private

Completed

Synopsis

Edit

SoftBank Vision Fund, a private equity firm, led a $200m Series E funding round in Alto Pharmacy, a drug delivery firm. “We’ve been laser-focused for the last seven years on building solutions to the foundational issues plaguing the broken pharmacy industry. We’re so proud of the progress the team has made, quietly solidifying our position as the market leader in the rapidly growing digital pharmacy market. We’re thrilled this new funding will enable us to continue to define this evolving industry and to help even more patients get the care they deserve," Jamie Karraker, Alto Co-Founder.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US